Clinical Trial Update: A Study of Hansoh (HS)-10502 in Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating Hansoh's HS-10502 in adults with advanced solid tumors, including ovarian, breast, pancreatic, prostate, and colorectal cancers, is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer
• Ovarian Cancer
• Pancreatic Cancer
• Prostate Cancer

Drugs mentioned

• HS-10502

Snippet

Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. | Conditions: Ovarian Cancer, Breast Cancer | Phase 1 | Status: RECRUITING